Opendata, web and dolomites

Predictix Antidepres

a user-friendly procedure that analyses genomic, clinical and demographic data to generate a personalized report with statistical analysis on the efficacy of antidepressants and their side effects

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Predictix Antidepres project word cloud

Explore the words cloud of the Predictix Antidepres project. It provides you a very rough idea of what is the project "Predictix Antidepres" about.

commercialisation    dekel    tool    disability    solutions    finalisation    world    sme    decision    financial    plans    care    practitioners    unfair    strategy    treatment    2012    burden    anxiety    takes    house    personalised    technologies    receives    patients    push    nervous    sequencing    criteria    expertise    medical    ip    efficiency    taliaz    made    requested    health    noted    accessed    action    dr    framework    standard    public    international    depression    fast    fits    quality    advantage    ec    fastest    mission    platform    organization    perfectly    solution    trade    optimized    recognizes    worldwide    patient    accurate    instrument    disease    central    oren    personalized    economic    personal    genetic    life    mental    benefits    medicine    date    remission    disorders    fairness    advancements    vital    prevalence    vision    predictix    treatments    adhd    genetics    barriers    services    suffering    founded    data    machine    learning    revenue    proprietary    science    too    clinical    measured   

Project "Predictix Antidepres" data sheet

The following table provides information about the project.

Coordinator
TALIAZ LTD 

Organization address
address: 2 PROF. YEHEZKEL KAUFMANN STREET TEXTILE CENTER, 15TH FLOOR
city: TEL-AVIV
postcode: 6801294
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.taliazhealth.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2019-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TALIAZ LTD IL (TEL-AVIV) coordinator 50˙000.00

Map

 Project objective

The World Health Organization recognizes mental disorders as one of the most significant public health challenges worldwide as measured by prevalence, burden of disease and disability , and depression as the world’s leading cause of disability. In EC and WHO action plans it is clearly requested that mental health services can be accessed without unfair financial barriers and that treatments are made available on criteria of both efficiency and financial fairness. In this framework personalised medicine is the fastest, most economic and optimized solution to the depression treatment problem. Indeed, the current push for a cost effective personalised medicine based on IT solution will also help with the commercialisation of our Predictix platform. The platform will allow medical practitioners to have up-to-date and accurate knowledge on each case and improve the care that patient receives, with an economic revenue too. Our solution allows for better delivery of available treatments – noted as a vital factor for increasing remission. TALIAZ was founded in 2012 by Dr. Dekel Taliaz and Oren Taliaz. Our mission is to set a new standard in personalized medicine improving quality of life for patients suffering from depression. Taliaz takes advantage of in-house expertise in genetics, data science and central nervous system related disease with the advancements in genetic sequencing and machine learning technologies, to develop leading personal medicine proprietary IP solutions for depression. Our future vision is to use Predictix™ also as a decision support tool for common health concerns such as ADHD and Anxiety. The SME Instrument project now perfectly fits our strategy and vision by enabling a fast finalisation of the platform development and by providing us the resources necessary to demonstrate the benefits of Predictix™ through an international clinical study.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREDICTIX ANTIDEPRES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREDICTIX ANTIDEPRES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More